D. Olivieri (Parma, Italy), J. C. Virchow (Rostock, Germany)
Implementation of national strategy in BA treatment in Russia
V. S. Yermakov (Kaluga, Russia)
|  |
Unlicensed use of high-dose inhaled corticosteroids in the UK occurs principally with fluticasone - an observational study of 26359 patients
M. Thomas, D. Leather, D. Price (Aberdeen, Stockley Park, United Kingdom)
| |
Potentially causative factors for the onset of Churg-Strauss syndrome: clinical study of eight cases
M. Tahara, K. Tamaki, T. Wakayama, R. Amitani, M. Watanabe, M. Tei, T. Minakata, Y. Osaki, D. Kaneda, M. Shintaku (Osaka, Japan)
| |
Study of improvement of exercise-indused bronchospasm by montelukast, a leukotriene antagonist
T. Sun, Y. Guo, X. Xu, H. Zhang (Beijing, China)
| |
Lung deposition distribution in astmatic patients of inhaled steroids when inhaled at the same time or 15 minutes after formoterol
S. Haeussermann, W. D. Bennett, P. Brand, T. A. Meyer, S. Roeder, G. Scheuch (Gauting, Germany; Chapel Hill, United States Of America)
| |
Exercise induced laryngeal dysfunction
O. D. Roksund, J. H. Heimdal, B. Skadberg, T. Halvorsen (Bergen, Norway)
| |
Impaired glucose metabolism in patients with status asthmaticus
W. Barg, E. Barg, K. Pesz, A. Obojski, K. Wytrychowski, B. Panaszek (Wroclaw, Poland)
| |
Changes in glucose metabolism during treatment with high doses of inhaled corticosteroids
D. L. Todevski, A. S. Gjorcev, M. M. Zdraveska, D. T. Dimitrievska (Skopje, Macedonia)
| |
Does spirometry in subjects GOLD stage zero change after one year of follow-up?
A. Nowinski, M. Bednarek, P. Bielen, J. Zielinski, D. Gorecka (Warsaw, Poland)
| |
Comparision of the results of pH probe between 4 groups of patients with and without respiratory problems
R. Meyer, G. B. Fischer, A. C. Souza (Porto Alegre, Brazil)
| |
Snoring is related to recurrent wheezing, rhinitis and dyspnea but not to type-1 allergy or bronchial hyperresponsiveness
L. G. Larsson, A. Lindberg, E. Rönmark, A. C. Jonsson, B. Lundbäck (Luleå, Stockholm, Sweden)
| |
Influence of allele variants of CYP2A6 and NAT2 genes on features of phenotype of tobacco smoker
N. Khodzhayants, T. Ivtchik, E. Iantchina, T. Rodygina, M. Mitupova (St Petersburg, Russia)
| |
Bone metabolism in asymptomatic smokers
E. A. Kochetkova, M. V. Volkova (Vladivostok, Russia)
| |
Efficacy and safety of bupropion for the treatment of smoking cessation in patients with chronic bronchitis
L. Kasper, K. Sladek, A. Szczeklik, A. Stojek, I. Bielerzewska Hauska (Kracow, Poznan, Poland)
| |
Evaluation of bronchodilator response to single dose tiotropium bromide
S. Celikel, A. Yilmaz, Z. Seyfikli, I. Etikan (Tokat, Turkey)
| |
Medical personnel and their knowledge of inhaler devices and the drugs available
S. Clover, J. M. Martin, R. M. L. Niven (Manchester, United Kingdom)
| |
Web based inhaler educational package: inclusion of basic principles is more effective than written information and video alone
A. Andrews, M. L. Everard (Sheffield, United Kingdom)
| |
Leukotriene receptor antagonist (LTRA) montelukast for the treatment of acute bronchiolitis in infants
M. Praprotnik, V. Macek (Ljubljana, Slovenia)
| |